Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
09/2002
09/26/2002WO2002024636A3 N-acylsulfonamide apoptosis promoters
09/26/2002US20020137978 Using as catalyst ruthenium or osmium carbene complexes containing an imidazolidine ligand
09/26/2002US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example
09/26/2002US20020137953 Method of producing high yield alditol acetals with mineral acids and surfactants
09/26/2002US20020137687 Novel compounds that inhibit tryptase activity
09/26/2002US20020137096 Solid phase synthesis; photolithography
09/26/2002CA2439539A1 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage)
09/25/2002EP1242379A1 Curcumin analogues for treating cancer
09/25/2002EP1242366A1 Salicylamides as serine protease and factor xa inhibitors
09/25/2002EP1242363A2 Cd45 inhibitors
09/25/2002EP0912534B1 Muscarinic antagonists
09/25/2002EP0817782B1 Phenyl derivatives useful as endothelin receptor antagonists
09/25/2002CN1371279A Metabolites of ecteinascidin 743
09/24/2002US6455587 Aromatic sulfonyl derivatives
09/24/2002US6455581 Inhibitors of hiv protease.
09/24/2002US6455550 N-alkanoylphenylalanine derivatives
09/24/2002US6455502 Compounds and compositions as protease inhibitors
09/19/2002WO2002072532A1 7, 9-substituted tetracycline compounds
09/19/2002WO2001007020A3 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
09/19/2002US20020133031 Catalytic asymmetric epoxidation
09/19/2002US20020132970 Exposure to high energy radiation
09/19/2002DE10112067A1 Verfahren zur Herstellung von 2,7-Dimethyl-2,4,6-octarienal-monoacetalen Process for the preparation of 2,7-dimethyl-2,4,6-octarienal-monoacetals
09/19/2002DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use
09/18/2002WO2001070678A2 Substituted biphenyl derivatives
09/18/2002EP1241157A1 Process for the preparation of 2,7-dimethyl-2,4,6-octatrienal-monoacetals
09/18/2002EP0929516B1 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
09/18/2002EP0865424B1 Pesticides
09/18/2002EP0804427B1 Lta4 hydrolase inhibitors
09/18/2002CN1370174A 2,3-benzodiazepine derivatives
09/18/2002CN1370158A Fatty acid synthase inhibitors
09/18/2002CN1370143A Propanoic acid derivatives that inhibit binding of integrins to their receptors
09/18/2002CN1370141A Fungicidal compounds having fluorovinyl-or-fluoropropenyl-oxyphenyloxime moiety and process for prepn. thereof
09/18/2002CN1369489A Process for reaction of CO2 on heterocyclic compound under co-catalysis of transistion metal complex and organic alkali
09/18/2002CN1369488A Process for synthesizing annular carbonate or oxazolidinone compounds
09/18/2002CN1091087C Method for preparing alcohols
09/18/2002CA2403500A1 Substituted biphenyl derivatives
09/17/2002WO2001070751A1 Reactive monomers for the oligonucleotide and polynucleotide synthesis, modified oligonucleotides and polynucleotides, and a method for producing the same
09/17/2002US6452000 Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate
09/17/2002US6451842 Cyclic amine derivatives and their use as drugs
09/17/2002US6451827 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
09/17/2002US6451824 Sulfonylaminocarboxylic acids
09/17/2002US6451798 Substituted alkyl piperazine derivatives
09/17/2002US6451792 Matrix metalloprotease inhibitors
09/17/2002US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds
09/17/2002CA2402822A1 Reactive monomers for the oligonucleotide and polynucleotide synthesis, modified oligonucleotides and polynucleotides, and a method for producing the same
09/17/2002CA2278878C Very large scale immobilized peptide synthesis
09/12/2002WO2002070541A2 Peptide deformylase inhibitors
09/12/2002WO2002044113A3 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
09/12/2002US20020128519 Condensing an ester phosphonium salt or an ester phosphonate with an aldehyde in a Wittig or Wittig-Horner reaction to give an acetal ester, reducing the ester to give an acetal alcohol, oxidizing the alcohol to the monoacetal
09/12/2002US20020128496 Process for the preparation of matrix metalloproteinase inhibitors
09/12/2002US20020128411 High hydrolytic stability; no variations in half-life; producing polyvinylidene fluoride-based polymers
09/12/2002CA2439827A1 Peptide deformylase inhibitors
09/11/2002EP1238988A1 Perfluorodiacylperoxides as polymerization initiators
09/11/2002EP0799206B1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
09/10/2002US6448414 Hydrolytic kinetic resolution of cyclic substrates
09/10/2002US6448412 Combinatorial chemistry libraries
09/10/2002US6448260 Endothelin receptor antagonists
09/06/2002WO2002068367A1 A method to inhibit ethylene responses in plants
09/06/2002WO2002043648A8 Compounds active at the glucocorticoid receptor ii
09/06/2002WO2002022577A3 Hydroxamate derivatives useful as deacetylase inhibitors
09/05/2002US20020123655 Process for preparing alkoxy- and aryloxy-phenols
09/05/2002US20020123527 Administering a 2-hydroxy-4-oxo- or 4,6-dioxo-6-pheny-l or naphthyl- hex-2-enoic acid; viricides; AIDS/ARC
09/04/2002EP1149066A4 Method of preparing alkylated salicylamides
09/04/2002EP0889878B1 Bisarylcyclobutene derivates as cyclooxygenase inhibitors
09/04/2002CN1090178C Tricyclic compounds having activity specific for integrins, particularly alpha V beta 3 integrins, method for preparing same
09/04/2002CN1090177C Preparation of aromatic nitriles
09/03/2002US6444849 Amide derivatives
09/03/2002CA2237189C 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
09/03/2002CA2140626C Hydroxamic acid derivatives as metalloproteinase inhibitors
08/2002
08/29/2002WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002WO2000068188A9 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
08/29/2002WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/29/2002US20020120153 From arylcarboxyaldehydes or 2-aryl-3-hydroxypropenoic acids
08/29/2002US20020120007 Benzamide inhibitors of factor Xa
08/29/2002US20020119977 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent
08/29/2002US20020119909 Organoleptic
08/29/2002CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/28/2002EP1233962A2 Novel heterocyclic compounds and their use as medicines
08/28/2002EP1233939A1 Process for preparing optically active alpha-hydroxy acids and derivatives thereof
08/28/2002CN1366518A Biphenyl butyric acid derivative as matrix metalloproteinase inhibitor
08/27/2002US6441246 Using dehydration agent
08/27/2002US6441236 Hydrolysis, amination
08/27/2002US6441173 Process for preparing indane carboxylate and cyclopentano [6] pyridine derivatives
08/27/2002US6440667 Analysis of target molecules using an encoding system
08/27/2002US6440440 Biocidal benzylbiphenyl derivatives
08/22/2002WO2002064550A1 Glucocorticoid receptor modulators
08/22/2002WO2002064547A2 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
08/22/2002WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals
08/22/2002WO2002064080A2 Matrix metalloproteinase inhibitors
08/22/2002US20020114902 Chiral doping agents with variable spiral pitch induction and application thereof to a reflective colour display
08/22/2002CA2437643A1 Matrix metalloproteinase inhibitors
08/22/2002CA2435376A1 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
08/21/2002EP1232150A1 Urea derivatives as anti-inflammatory agents
08/21/2002EP1127060A4 Hydroboronation process
08/20/2002US6436973 Leukotriene enzyme inhibitors, administered as antiarthritic and antiinflammatory agents; prophylaxis of psoriasis and liver disorders
08/20/2002US6436940 Combined effects of dopamine d4 receptor ligands and serotonin reuptake inhibitors; schizophrenia; antidepressant; anxiolytic agents; psychological disorders; panic, sleep and obsessive compulsive disorders; antiischemic agents
08/20/2002US6436914 2-hydroxy-3—(4-hydroxy-3-sulfonamidophenyl)—propylamines useful as beta 3 adrenergic agonists
08/20/2002US6436152 Substituted 2-aminoalky-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same
08/15/2002WO2002062790A1 Preparation of n-methylparoxetine and related intermediate compounds
08/15/2002WO2002062307A1 Colouring agents for keratin fibres containing (1.1'-biphenyl)-2.4-diamine derivatives in addition to novel (1.1'-biphenyl)-2.4-diamine-derivatives
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 183